UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Toxicologic Pathology in the 21st Century

Toxicologic pathology, 2013-07, Vol.41 (5), p.689-708

Ettlin, Robert A.

2013

Volltextzugriff (PDF)

International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-type, Nonclinical Toxicity Studies

Toxicologic pathology, 2010-10, Vol.38 (6), p.984-992

2010

Volltextzugriff (PDF)

Global Recognition of Qualified Toxicologic Pathologists: Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies

Toxicologic pathology, 2009-06, Vol.37 (4), p.553-561

2009

Volltextzugriff (PDF)

Successful Drug Development Despite Adverse Preclinical Findings Part 1: Processes to Address Issues and Most Important Findings

Journal of Toxicologic Pathology, 2010, Vol.23(4), pp.189-211

2010

Volltextzugriff (PDF)

Successful Drug Development Despite Adverse Preclinical Findings Part 2: Examples

Journal of Toxicologic Pathology, 2010, Vol.23(4), pp.213-234

2010

Volltextzugriff (PDF)

Global Recognition of Qualified Toxicologic Pathologists: Where We Are Now and Where We Need to Go

Toxicologic pathology, 2008-07, Vol.36 (5), p.753-759

2008

Volltextzugriff (PDF)

Global recognition of qualified toxicologic pathologists: Credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studies

Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie, 2010-07, Vol.62 (4), p.413-422

2010

Volltextzugriff (PDF)

Global Recognition of Qualified Toxicologic Pathologists: Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies

Journal of Toxicologic Pathology, 2009, Vol.22(2), pp.143-152

2009

Volltextzugriff (PDF)

International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies

Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie, 2011, Vol.63 (1), p.187-195

2011

Volltextzugriff (PDF)

International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-Type, Nonclinical Toxicity Studies

Journal of Toxicologic Pathology, 2010, Vol.23(3), pp.171-181

2010

Volltextzugriff (PDF)

Global Recognition of Qualified Toxicologic Pathologists: Where We Are Now and Where We Need to Go

Journal of Toxicologic Pathology, 2007, Vol.20(4), pp.267-272

2007

Volltextzugriff (PDF)

Toxicologic Pathology in the New Millennium

Toxicologic pathology, 2002-01, Vol.30 (1), p.160-163

2002

Volltextzugriff (PDF)

Global recognition of qualified toxicologic pathologists: Where we are now and where we need to go

Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie, 2008-06, Vol.60 (1), p.1-8

2008

Volltextzugriff (PDF)

Abstract 159: Pharmacological characterization of the selective, orally bioavailable, potent dual PI3K/mTORC1/2 inhibitor PQR530

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.159-159

2017

Volltextzugriff (PDF)

Abstract 393A: Pharmacological characterization of the selective, orally bioavailable, potent mTORC1/2 inhibitor PQR620

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.393-393A

2016

Volltextzugriff (PDF)

Careers in toxicology in Europe : Options and requirements : Report of a workshop organized on behalf of the Individual members of EUROTOX during the EUROTOX Congress 2000 in London (September 17-20, 2000)

Archives of toxicology, 2001-07, Vol.75 (5), p.251-261

2001

Volltextzugriff (PDF)

Abstract 4514: PQR309: A potent, brain-penetrant, dual pan-PI3K/mTOR inhibitor with excellent oral bioavailability and tolerability

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4514-4514

2015

Volltextzugriff (PDF)

Causes of Death in Rodent Toxicity and Carcinogenicity Studies

Toxicologic pathology, 1994-03, Vol.22 (2), p.165-178

1994

Volltextzugriff (PDF)

In memory of Dr. med. Christian M. Hodel 1936–2003

Toxicology letters, 2004-06, Vol.151 (1), p.1-3

Ettlin, Robert A

2004

Volltextzugriff (PDF)

Successful Drug Development Despite Adverse Preclinical Findings Part 1: Processes to Address Issues and Most Important Findings

Journal of Toxicologic Pathology, 2010, Vol.23 (4), p.189-211

2010

Volltextzugriff (PDF)

Successful Drug Development Despite Adverse Preclinical Findings Part 2: Examples

Journal of Toxicologic Pathology, 2010, Vol.23 (4), p.213-234

2010

Volltextzugriff (PDF)

Morphologic and Immunohistochemical Characterization of Leydig Cell Tumor Variants in Wistar Rats

Toxicologic pathology, 1991-04, Vol.19 (3), p.280-286

1991

Volltextzugriff (PDF)

Global Recognition of Qualified Toxicologic Pathologists

Journal of toxicologic pathology, 2009-04, Vol.22 (2), p.143

2009

Volltextzugriff (PDF)

Quantification of hepatocytic proliferation in the laboratory mouse

Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie, 1994-07, Vol.46 (2), p.95-100

1994

Volltextzugriff (PDF)

Global Recognition of Qualified Toxicologic Pathologists

Journal of toxicologic pathology, 2007-10, Vol.20 (4), p.267

2007

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Englisch
(40)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Toxicologic Pathology in the 21st Century

International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-type, Nonclinical Toxicity Studies

Global Recognition of Qualified Toxicologic Pathologists: Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies

Successful Drug Development Despite Adverse Preclinical Findings Part 1: Processes to Address Issues and Most Important Findings

Successful Drug Development Despite Adverse Preclinical Findings Part 2: Examples

Global Recognition of Qualified Toxicologic Pathologists: Where We Are Now and Where We Need to Go

Global recognition of qualified toxicologic pathologists: Credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studies

Global Recognition of Qualified Toxicologic Pathologists: Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies

International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies

International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-Type, Nonclinical Toxicity Studies

Global Recognition of Qualified Toxicologic Pathologists: Where We Are Now and Where We Need to Go

Toxicologic Pathology in the New Millennium

Global recognition of qualified toxicologic pathologists: Where we are now and where we need to go

Abstract 159: Pharmacological characterization of the selective, orally bioavailable, potent dual PI3K/mTORC1/2 inhibitor PQR530

Abstract 393A: Pharmacological characterization of the selective, orally bioavailable, potent mTORC1/2 inhibitor PQR620

Careers in toxicology in Europe : Options and requirements : Report of a workshop organized on behalf of the Individual members of EUROTOX during the EUROTOX Congress 2000 in London (September 17-20, 2000)

Abstract 4514: PQR309: A potent, brain-penetrant, dual pan-PI3K/mTOR inhibitor with excellent oral bioavailability and tolerability

Causes of Death in Rodent Toxicity and Carcinogenicity Studies

In memory of Dr. med. Christian M. Hodel 1936–2003

Successful Drug Development Despite Adverse Preclinical Findings Part 1: Processes to Address Issues and Most Important Findings

Successful Drug Development Despite Adverse Preclinical Findings Part 2: Examples

Morphologic and Immunohistochemical Characterization of Leydig Cell Tumor Variants in Wistar Rats

Global Recognition of Qualified Toxicologic Pathologists

Quantification of hepatocytic proliferation in the laboratory mouse

Global Recognition of Qualified Toxicologic Pathologists

Suchergebnisse filtern